The Antibiofilm Effect of a Medical Device Containing TIAB on Microorganisms Associated with Surgical Site Infection.

Anti-Bacterial Agents / chemistry Bacteria / drug effects Biofilms / drug effects Coated Materials, Biocompatible Equipment and Supplies / adverse effects Humans Microbial Sensitivity Tests Silver Compounds / chemistry Surgical Wound Infection / etiology
Enterococcus faecalis Staphylococcus aureus TIAB antibiofilm activity antimicrobial activity surgical site infection

Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
19 Jun 2019
Historique:
received: 14 05 2019
revised: 10 06 2019
accepted: 18 06 2019
entrez: 29 6 2019
pubmed: 30 6 2019
medline: 18 12 2019
Statut: epublish

Résumé

Surgical site infections (SSIs) represent the most common nosocomial infections, and surgical sutures are optimal surfaces for bacterial adhesion and biofilm formation.

Identifiants

DOI: 10.3390/molecules24122280 PMID: 31248162 PMC: PMC6630542
pubmed: 31248162
pii: molecules24122280
doi: 10.3390/molecules24122280
pmc: PMC6630542
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Coated Materials, Biocompatible 0
Silver Compounds 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Infect Control Hosp Epidemiol. 1992 Oct;13(10):606-8
pubmed: 1334988
Antimicrob Agents Chemother. 2005 Jul;49(7):2612-7
pubmed: 15980327
Microb Drug Resist. 2006 Summer;12(2):83-90
pubmed: 16922622
J Am Coll Surg. 2006 Oct;203(4):481-9
pubmed: 17000391
Clin Infect Dis. 2007 Sep 1;45 Suppl 2:S137-47
pubmed: 17683018
BMC Infect Dis. 2008 Mar 07;8:34
pubmed: 18328101
Surg Infect (Larchmt). 2008 Aug;9(4):451-7
pubmed: 18687027
J Hosp Infect. 2008 Nov;70 Suppl 2:3-10
pubmed: 19022115
J Med Assoc Thai. 2009 Jun;92(6):770-5
pubmed: 19530582
Antimicrob Agents Chemother. 2011 Oct;55(10):4659-63
pubmed: 21825293
Surg Infect (Larchmt). 2011 Dec;12(6):483-9
pubmed: 22142314
Pathog Dis. 2014 Apr;70(3):414-22
pubmed: 24535842
PLoS One. 2014 Jul 01;9(7):e101426
pubmed: 24983633
Mater Sci Eng C Mater Biol Appl. 2014 Nov;44:278-84
pubmed: 25280707
J Biol Regul Homeost Agents. 2015 Jul-Sep;29(3 Suppl 1):127-30
pubmed: 26511192
Front Microbiol. 2015 Dec 16;6:1369
pubmed: 26733944
ACS Appl Mater Interfaces. 2016 Jun 22;8(24):15067-75
pubmed: 27064187
J Orthop Res. 2017 Apr;35(4):925-933
pubmed: 27208547
Nat Rev Microbiol. 2016 Aug 11;14(9):563-75
pubmed: 27510863
Front Microbiol. 2016 Nov 16;7:1831
pubmed: 27899918
Int J Nanomedicine. 2017 Feb 14;12:1227-1249
pubmed: 28243086
J Appl Microbiol. 2017 Nov;123(5):1068-1087
pubmed: 28650591
Materials (Basel). 2016 May 06;9(5):null
pubmed: 28773468
Molecules. 2017 Sep 19;22(9):null
pubmed: 28925959
Nat Rev Microbiol. 2017 Dec;15(12):740-755
pubmed: 28944770
PLoS One. 2018 Jan 9;13(1):e0190912
pubmed: 29315313
Pharmaceutics. 2018 Jan 14;10(1):null
pubmed: 29342903
Eur J Pharm Biopharm. 2018 Jun;127:130-141
pubmed: 29462687
Int J Biol Macromol. 2018 Aug;115:165-175
pubmed: 29627463
J Mater Sci Mater Med. 2018 Apr 23;29(5):50
pubmed: 29687280
Spectrochim Acta A Mol Biomol Spectrosc. 2018 Dec 5;205:503-507
pubmed: 30064114
Front Pharmacol. 2018 Jul 18;9:776
pubmed: 30072898
Materials (Basel). 2018 Aug 20;11(8):null
pubmed: 30127307
J Microbiol Biotechnol. 2018 Oct 28;28(10):1664-1670
pubmed: 30178650
Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5729-5739
pubmed: 30229851
Molecules. 2018 Sep 18;23(9):null
pubmed: 30231567
Molecules. 2018 Dec 10;23(12):null
pubmed: 30544765
Heliyon. 2019 Mar 14;5(3):e01333
pubmed: 30923765
Sci Rep. 2019 Jun 5;9(1):8303
pubmed: 31165752

Auteurs

Valentina Puca (V)

Department of Medicine and Aging Science, "G. d'Annunzio" of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy. valentina.puca@unich.it.
Center of Excellence on Aging and Translational Medicine (CeSI-MeT), Via Luigi Polacchi 11, 66100 Chieti, Italy. valentina.puca@unich.it.

Tonino Traini (T)

Department of Medical, Oral, and Biotechnological Sciences, "G. d'Annunzio" University of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy. tonino.traini@unich.it.

Simone Guarnieri (S)

Center of Excellence on Aging and Translational Medicine (CeSI-MeT), Via Luigi Polacchi 11, 66100 Chieti, Italy. simone.guarnieri@unich.it.
Department of Neuroscience Imaging and Clinical Sciences, "G. d'Annunzio" University Chieti-Pescara, Via Luigi Polacchi 11, 66100 Chieti, Italy. simone.guarnieri@unich.it.

Simone Carradori (S)

Department of Pharmacy, "G. d'Annunzio" University of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy. simone.carradori@unich.it.
ORCID: 0000-0002-8698-9440

Francesca Sisto (F)

Department of Biomedical, Surgical and Dental Sciences, University of Milan, Via della Commenda 10, 20122 Milan, Italy. francesca.sisto@unimi.it.

Nicola Macchione (N)

Department of Urology, University of Milan, ASST Santi Paolo e Carlo, Via Antonio di Rudinì 8, 20142 Milan, Italy. nicola.macchione@asst-santipaolocarlo.it.
ORCID: 0000-0002-9921-8012

Raffaella Muraro (R)

Department of Medical, Oral, and Biotechnological Sciences, "G. d'Annunzio" University of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy. raffaella.muraro@unich.it.

Gabriella Mincione (G)

Department of Medical, Oral, and Biotechnological Sciences, "G. d'Annunzio" University of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy. gabriella.mincione@unich.it.

Rossella Grande (R)

Center of Excellence on Aging and Translational Medicine (CeSI-MeT), Via Luigi Polacchi 11, 66100 Chieti, Italy. r.grande@unich.it.
Department of Pharmacy, "G. d'Annunzio" University of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy. r.grande@unich.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › The Antibiofilm Effect of a Medical Device...
questionsmedicales.fr › Bactéries › The Antibiofilm Effect of a Medical Device...
questionsmedicales.fr › Phénomènes microbiologiques › Biofilms › The Antibiofilm Effect of a Medical Device...
questionsmedicales.fr › Technologie, industrie et agriculture › Produits manufacturés › Matériaux biomédicaux et dentaires › Matériaux biocompatibles › Matériaux revêtus, biocompatibles › The Antibiofilm Effect of a Medical Device...
questionsmedicales.fr › Équipement et fournitures › The Antibiofilm Effect of a Medical Device...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The Antibiofilm Effect of a Medical Device...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › The Antibiofilm Effect of a Medical Device...
questionsmedicales.fr › Produits chimiques inorganiques › Composés de l'argent › The Antibiofilm Effect of a Medical Device...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Complications postopératoires › Infection de plaie opératoire › The Antibiofilm Effect of a Medical Device...